The strength of synaptic inhibition can be controlled by the stability and endocytosis of surface and synaptic GABA A receptors (GABA A Rs), but the surface receptor dynamics that underpin GABA A R recruitment to dendritic endocytic zones (EZs) have not been investigated. Stabilization of GABA A Rs at EZs is likely to be regulated by receptor interactions with the clathrin-adaptor AP2, but the molecular determinants of these associations remain poorly understood. Moreover, although surface GABA A R downmodulation plays a key role in pathological disinhibition in conditions such as ischemia and epilepsy, whether this occurs in an AP2-dependent manner also remains unclear. Here we report the characterization of a novel motif containing three arginine residues ( 405 RRR 407 ) within the GABA A R ␤3-subunit intracellular domain (ICD), responsible for the interaction with AP2 and GABA A R internalization. When this motif is disrupted, binding to AP2 is abolished in vitro and in rat brain. Using single-particle tracking, we reveal that surface ␤3-subunit-containing GABA A Rs exhibit highly confined behavior at EZs, which is dependent on AP2 interactions via this motif. Reduced stabilization of mutant GABA A Rs at EZs correlates with their reduced endocytosis and increased steady-state levels at synapses. By imaging wild-type or mutant super-ecliptic pHluorin-tagged GABA A Rs in neurons, we also show that, under conditions of oxygen-glucose deprivation to mimic cerebral ischemia, GABA A Rs are depleted from synapses in dendrites, depending on the 405 RRR 407 motif. Thus, AP2 binding to an RRR motif in the GABA A R ␤3-subunit ICD regulates GABA A R residency time at EZs, steady-state synaptic receptor levels, and pathological loss of GABA A Rs from synapses during simulated ischemia.
Introduction
GABA A receptors (GABA A Rs) are the main mediators of inhibitory neurotransmission in the CNS and play an essential role in maintaining the excitatory/inhibitory balance required for correct brain function . Modulating the abundance of GABA A Rs at synaptic sites is a key mechanism for determining the strength of synaptic inhibition (Arancibia-Cárcamo and ). However, the exact molecular processes that underlie changes in GABA A R numbers at synapses and hence synaptic efficacy under normal or pathological conditions remain poorly understood.
GABA A Rs are dynamic entities, in terms of both their lateral mobility at the plasma membrane (Bannai et al., 2009; Muir et al., 2010) and their trafficking to and from the cell surface . Clathrin-mediated endocytosis of GABA A Rs is dependent on the clathrin-adaptor AP2 and rapidly modulates synaptic GABA A R number, inhibitory synaptic strength, neuronal excitability, and, ultimately, animal behavior (Kittler et al., 2000 (Kittler et al., , 2005 Chen et al., 2006; Kurotani et al., 2008; Tretter et al., 2009) . Although a number of recent studies have investigated the diffusion of GABA A Rs into and out of synapses, far less is known about GABA A R membrane dynamics at endocytic zones (EZs) and how GABA A Rs are recruited to and stabilized at these regions.
Disrupted GABA A R trafficking contributes to altered information processing in pathological conditions such as epilepsy and ischemia, in which acute receptor surface downmodulation and loss of synaptic GABA A Rs leads to compromised neuronal inhibition and altered excitability states, but the underlying mechanisms remain unclear (Mielke and Wang, 2005; Naylor et al., 2005; Tan et al., 2007; ). Indeed, although both clathrin-dependent and -independent (e.g., caveolar-dependent) pathways for GABA A R endocytosis have been described (Kittler et al., 2000; Bradley et al., 2008) , the specific contribution of AP2-dependent pathways for synaptic receptor loss in epilepsy or ischemia remains unclear. Deciphering the molecular mechanisms and endocytic pathways responsible for synaptic GABA A R downmodulation is therefore central to understanding how synaptic inhibition is regulated in the healthy brain and could lead to identification of potential target pathways of pathological receptor downmodulation for therapeutic intervention during disinhibition in disease.
Here, we characterize the molecular interactions that underlie internalization of GABA A Rs containing ␤3 subunits, which are present in a large proportion of receptor subtypes in the hippocampus and cortex, regions that are particularly vulnerable to excitotoxicity (Lo et al., 2003) . Using a combination of molecular, biochemical, and imaging approaches, we identify a three arginine (RRR) motif within the GABA A R ␤3-subunit intracellular domain (ICD) that mediates the clathrin-dependent endocytosis of GABA A Rs via direct binding to AP2. Furthermore, by combining single-particle tracking with mutagenesis of the RRR motif, we reveal that GABA A Rs are reversibly stabilized at EZs, depending on interactions with AP2. Additionally, we demonstrate that loss of synaptic GABA A Rs in an in vitro model of ischemia is dependent on AP2-binding via this motif and that blocking this mechanism can reduce cell death. Thus, direct binding of GABA A R ICDs to AP2 regulates GABA A R recruitment into EZs, steady-state GABA A R levels at synapses, and provides a key mechanism for receptor downmodulation in pathology.
Materials and Methods
cDNA cloning. The ␤3 GABA A R-subunit mutants were made by sitedirected mutagenesis on a pRK5 myc ␤3 backbone. The ICDs of these mutants were amplified by PCR, and the resulting fragment was inserted into the BamH1/Not1 sites of pGEX-4T3.
SEP ␥2 (Superecliptic pHluorin) has been described previously (Muir et al., 2010) . Untagged ␣1 was in pRK5 and was described previously (Twelvetrees et al., 2010) . mRFPrab5 [Addgene plasmid 14437 (Vonderheit and Helenius, 2005) ] and clathrin-light chain polypeptide-EYFP [Addgene plasmid 21741 (Chen and Zhuang, 2008) ] were from Addgene. EGFP was from Clontech.
Antibodies. The following primary antibodies were used: mouse monoclonal anti-Myc was obtained from 9E10 hybridoma cells [immunofluorescence (IF) and ELISA, supernatant 1:100], anti-AP50 [Western blot (WB), 1:250; BD Biosciences], anti-GFP (IF, 1:500; clone N86/38; Neuromab), rabbit polyclonal anti-myc [IF, 1:200 ; quantum dot (QD) imaging, 1:100; Santa Cruz Biotechnology], rabbit anti-vesicular inhibitory amino acid transporter (VIAAT) [a kind gift from B. Gasnier, Universite Paris, Descartes, France (Dumoulin et al., 1999) ; IF, 1:1000], anti-␣1 GABA A R subunit (WB, 1:5; clone N95/35; Neuromab), anti-␤-adaptin (WB, 1:500; Sigma), vesicular GABA transporter (VGAT)-Oyster 488 (live imaging, 1:1000; Synaptic Systems), and anti-myc (QD imaging, 1:100; Millipore Bioscience Research Reagents).
Cell culture. Cultures of cortical and hippocampal neurons were prepared from E18 Sprague Dawley rat embryos of either sex as described previously . Neurons were transfected by nucleofection before plating as described previously Macaskill et al., 2009; Twelvetrees et al., 2010) . COS-7 cells were maintained in DMEM (Invitrogen), supplemented with 10% heat-inactivated fetal bovine serum and penicillin-streptomycin, and transfected by electroporation for biochemistry and by nucleofection (Amaxa) for immunocytochemistry.
GST fusion protein pull-down assays from rat brain homogenate. Pulldowns from brain were performed as described previously . Briefly, adult rat brain was homogenized in pull-down buffer (50 mM HEPES, pH 7.5, 0.5% Triton X-100, 150 mM NaCl, 1 mM EDTA, and 1 mM PMSF with antipain, pepstatin, and leupeptin at 10 g/ml) and solubilized for 2 h. Solubilized material was ultracentrifuged at 66,000 ϫ g for 40 min at 4°C, and the supernatant (solubilized protein) was exposed to 10 -20 g of GST fusion protein attached to glutathioneagarose beads for 1 h at 4°C. Beads were then washed extensively and analyzed by SDS-PAGE and WB.
In vitro translation of [ 35 S]methionine-labeled protein and GST pulldown assays. Residues 156 -433 of the 2 subunit of AP2 were in vitro translated using TNT SP6 Quick Coupled Transcription/Translation system (Promega) and labeled with [
35 S]methionine (GE Healthcare) following the protocol of the manufacturer . Five microliters of labeled protein were incubated with 10 -20 g of GST fusion protein in pull-down buffer (as above) for 2 h at 4°C. The beads were washed and resolved by SDS-PAGE followed by staining with Coomassie blue. Radioactivity was detected with a phosphor-storage screen and PhosphorImager. Bacterially expressed wild-type (WT) or mutant (mut) His-tagged 2 were used for nonradioactive in vitro pull-downs with GST fusion proteins and analyzed by SDS-PAGE, followed by staining with Coomassie blue .
Surface plasmon resonance. Surface plasmon resonance (SPR) experiments were performed as described previously ) on a BIAcore 2000 instrument (BIAcore).
Immunofluorescence. For receptor internalization assays in COS-7 cells, receptors were live labeled with 9E10 anti-myc antibody in HEPES buffer (in mM: 25 HEPES, 140 NaCl, 5.4 KCl, 1.8 CaCl 2 , and 15 glucose, pH 7.4) at 4°C. Labeled receptors were allowed to internalize for 30 min at 37°C, and surface antibody was stripped away using 0.2 M acetic acid and 0.5 M NaCl before fixation as described previously (ArancibiaCárcamo et al., 2009) . Internalized receptors were identified using Alexa Fluor-594-conjugated or Alexa Fluor-488-conjugated anti-mouse secondary antibody (1:1000; Invitrogen) and confocal microscopy. Quantification of receptor internalization was performed by determining the area of the internalized receptors and normalization to the cell area (as given by GFP fluorescence; described by Hanley and Henley, 2005) or by measuring the colocalization of the internalized receptors with the early endosomal marker rab5.
Receptor internalization assays in neurons were performed similarly to what has been described previously (Scott et al., 2004) , with modifications. Briefly, transfected neurons were incubated at room temperature with anti-9E10 antibody and placed at 37°C for 30 min to enable internalization. After washing, cells were fixed and surface receptors were stained with secondary Alexa Fluor-488 secondary antibody. Cells were permeabilized and stained with Alexa Fluor-594 secondary antibody to label the total receptor population and then visualized by confocal microscopy. For quantification of receptor internalization, red fluorescence that was not colocalized with green fluorescence (surface receptors) was calculated as the internalized receptor population and normalized to total receptor population.
Neurons for surface staining were fixed with 4% paraformaldehyde (PFA)/4% sucrose/PBS, pH 7, for 4 min and blocked with block solution (PBS, 10% horse serum, and 0.5% BSA) for 10 min. Neurons were incubated for 1 h with anti-9E10, followed by permeabilization with block solution containing 0.2% Triton X-100. Neurons were then incubated with anti-VIAAT antibody and subsequently with Alexa Fluor-488 and Alexa Fluor-594 secondary antibodies (1:1000; Invitrogen). After extensive washing, coverslips were mounted on microscope slides using ProLong Gold antifade reagent (Invitrogen) and sealed with nail varnish. Images were acquired using a Carl Zeiss Pascal confocal microscope and digitally captured using LSM software.
Surface receptor ELISA assay. Quantification of surface myc-tagged GABA A Rs was performed by colorimetric cell ELISA as described previously (Mielke and Wang, 2005) . Briefly, 8 -9 DIV cultured cortical neurons were fixed with 4% PFA/sucrose for 5 min and then blocked under nonpermeabilizing conditions (PBS and 3% BSA). Cells were incubated for 1 h with anti-9E10 (1:100) and then for 1 h with HRP-conjugated anti-mouse secondary antibody (1:2000; Rockland). After extensive washing, cells were incubated with 1 vol of o-phenylenediamine substrate (Sigma) for 3 min. Reactions were stopped using 0.2 vol of 3N HCl, and 1 ml of supernatant was used to determine the absorbance at 492 nm. For N-ethylmaleimide-sensitive factor (NSF) inhibition experiments, COS-7 cells expressing myc-tagged GABA A Rs were incubated with a TAT-fused NSF inhibitory peptide (NSFi) or scrambled control peptide for 75 min (Anachem) (Morrell et al., 2005; Chou et al., 2010) , followed by the ELISA procedure described above. NaCl, 5.4 KCl, 1.8 CaCl 2 , and 15 glucose, pH 7.4) to label SEP ␥2 clusters. Cells were then fixed and blocked as described above and labeled with rabbit anti-myc antibody to label myc ␤3-subunitcontaining receptors. Coverslips were washed and mounted as described above. Quantification of cotransfection was performed by assessing whether the SEP ␥2-transfected neurons in a 40ϫ field of view were also expressing myc ␤3 subunits. This was then expressed as a percentage of the SEP ␥2-transfected neurons. Cells were imaged at 12-15 DIV as described previously (ArancibiaCárcamo et al., 2009 ). Carbonate-buffered solution contained 126 mM NaCl, 2.5 mM KCl, 1 mM MgCl 2 , 2 mM CaCl 2 , 1 mM NaH 2 PO 4 , 24 mM NaHCO 3 , and 10 mM glucose and was gassed with 95% O 2 , 5% CO 2 . For oxygen-glucose deprivation (OGD), 7 mM sucrose was used in place of glucose, and the solution was gassed with 95% N 2 , 5% CO 2 . Both solutions were bubbled for 30 min before addition of CaCl 2 to prevent precipitate formation. Solutions were perfused at a constant rate of ϳ2 ml/min and heated to 35-37°C. For OGD experiments, the solution was switched from control to OGD buffer at t ϭ 0 min. Super-ecliptic pHluorin fluorescence was captured using an Olympus microscope (BX51WI) with a 60ϫ Olympus objective coupled to an EM-CCD camera (Ixon; Andor). Excitation was provided by a mercury-spiked xenon arc lamp (Cairn). Bandpass filters for excitation and emission were used (470/40 and 525/50 nm, respectively). Images (averages of eight consecutive exposures of 150 ms) were acquired every 10 min. The StackReg macro (Thévenaz et al., 1998 ) was used to correct for minor x-y drift that may have occurred between time points. Using NIH ImageJ, regions of interest were drawn around each non-somatic fluorescent cluster. After background subtraction, the average intensity across SEP-GABA A R clusters in each time point was used as readout. This value was normalized to that at t ϭ 0 min.
For cell death assays, hippocampal cultures were transduced with peptides (␤3 peptide, KTHLRRRSSQLK; control peptide, INRVDAHE-NAAAAPM) for 1 h using Chariot reagent (active motif) following the instructions of the manufacturer Twelvetrees et al., 2010) . After peptide transduction, cultures were exposed to 40 min OGD using a Billups-Rothenberg modular incubator chamber as described previously (Dixon et al., 2009 ) using the control and OGD buffers described above. To monitor cell death, 24 h after OGD treatment, neurons were stained with propidium iodide (PI) (4 g/ml) for 1 h, followed by fixation with 4% PFA/sucrose and staining with DAPI. For each experiment, six to eight fields of view were imaged per condition, and the number of DAPI-positive nuclei that were PI stained was determined.
Single-particle tracking. Labeling of myc-tagged GABA A Rs ( myc ␤3
WT and myc ␤3 RRR/AAA ) with QDs was performed using a rabbit anti-myc antibody (Santa Cruz Biotechnology) or mouse anti-myc antibody (Millipore Bioscience Research Reagents) and anti-rabbit or anti-mouse 605 nm QDs (Invitrogen). Labeling was performed at room temperature with primary antibody (0.1 g/ml, 1:100) for 8 min in block solution (imaging media containing 10% horse serum) and then QD incubation (0.5 nM) for 2 min in block solution as above. QD movies were recorded for 200 frames at 8.5 Hz (23.5 s duration). The imaging media for these experiments contained the following (in mM): 125 NaCl, 5 KCl, 1 MgCl 2 , 2 CaCl 2 , 10 D-glucose, and 10 HEPES, adjusted to pH 7.4. Labeling of inhibitory presynaptic terminals with VGAT-Oyster 488 (1:1000; Synaptic Systems) was performed by incubation of coverslips in 200 l of imaging media for 30 min at 37°C, 5% CO 2 , and we found that spontaneous activity in the neuronal culture was sufficient to load the dye into inhibitory presynaptic terminals. Similar staining could be achieved with a depolarizing high KCl stimulus (60 mM, 5 min; data not shown).
For analysis of single GABA A R dynamics, trajectories were created automatically from movies of QD-tagged receptors. For each frame, an image segmentation algorithm was run that classifies image pixels based on their local symmetry at a specified scale. Pixels with maximal rotational symmetry (corresponding to local maxima in intensity) were classified as being attributable to QDs, and their locations were given to subpixel accuracy by taking the weighted average of connected target pixels. The pointing accuracy of the system is ϳ50 nm. Tracks were generated by linking particle positions between frames, using homemade software written in Mathematica (Wolfram Research). Briefly, the Euclidian distance between frames was minimized using a function that allowed for particle blinking such that tracks could be connected across blinking events. Instantaneous diffusivities (D inst ) were calculated from interframe displacements along consecutive track segments according to the 2D diffusion law (x 2 ϭ 4 D inst t), and fitting to the first five points of the displacement curve was used to estimate the instantaneous diffusion coefficient. QD track segments were classified as being inside clathrincoated pits (labeled by clathrin-YFP) if their midpoint was within 0.4 m of the center of a pit. Cluster positions were found automatically from images taken immediately before the corresponding QD movie using the image segmentation algorithm described above. For imaging at inhibitory synapses, QD track segments were classified as synaptic if their midpoint was within 0.75 m of the center of a VGAT punctum.
Statistical analysis. All experiments were performed at least three times from different preparations. Unless otherwise stated, p values given are from two-tailed t tests, and values are given as mean Ϯ SEM. Error bars represent SEM.
Results
AP2 binds to a patch of basic amino acid residues within the ␤3-subunit ICD Little is currently known regarding the dynamics of GABA A Rs at EZs in neuronal dendrites for their subsequent endocytosis. Recruitment of GABA A Rs to these sites is likely to depend on direct associations between the 2 subunit of the clathrin adaptor AP2 (2-AP2) and GABA A R-subunit ICDs (Kittler et al., 2005) . To allow us to study the role of GABA A R ␤3 subunits in regulating the dynamics of GABA A R endocytosis, we set out to identify ␤3-subunit mutants no longer able to directly bind 2-AP2. To this end, we made multiple GST fusion proteins of the ␤3-subunit ICD with sequential regions of the ICD deleted ( Fig. 1 A) and tested their ability to bind in vitro translated 35 S-labeled 2-AP2. Quantification of the radioactive protein bound to the various GST-␤3 ICD deletions revealed that the binding of 2-AP2 to deletion 6 (⌬395-414) was significantly reduced compared with binding to the other GST-␤3 ICD deletions (n ϭ 5, *p Ͻ 0.05; Fig. 1 B, C). To ascertain whether a similar loss of binding was observed for 2-AP2 from brain, we used a similar pull-down approach to assess the binding of GST-␤3 deletion proteins to 2-AP2 from rat brain homogenate. In agreement with our findings using radiolabeled 2-AP2, the binding of brain 2-AP2 to deletion 6 was significantly reduced compared with the other GST-␤3 deletion proteins (n ϭ 4, *p Ͻ 0.05; Fig. 1 D, E), further confirming that the region deleted in GST-␤3 deletion 6 is important for the binding of 2-AP2 to the ␤3-subunit ICD.
The 20 aa region identified in Figure 1 A-E (deletion 6) contains a stretch of amino acids enriched with basic lysine and arginine residues, similar to motifs identified in other AP2-binding membrane proteins, including synaptotagmin-1 (Syt-1) (Haucke et al., 2000) , the ␣1␤-adrenergic receptor (Diviani et al., 2003) and AMPA receptors (Kastning et al., 2007) . To determine whether these residues within the ␤3 subunit ( 400 KKTHL-RRR 407 ) were responsible for AP2 binding, we mutated the basic amino acids within this region to alanines (GST-␤3 7A ; Fig. 1 F) . A dileucine motif within the ␤2 GABA A R-subunit ICD has also been suggested to be a determinant of clathrin-dependent internalization of the receptor (Herring et al., 2003) . To verify whether a conserved dileucine motif in the ␤3-subunit ICD was also important for AP2 binding, we also mutated this motif to alanine ( Fig. 1 F) , to give GST-␤3 ILL/AAA , and additionally constructed a double mutant, GST-␤3 7AϩILL/AAA with both sites mutated. These fusion proteins were used in pull-down assays with 35 Slabeled 2-AP2 to analyze the effect of these specific mutations on the AP2/␤3 ICD interaction. Mutation of the seven basic res-idues greatly reduced binding of 2-AP2 to the ␤3-subunit ICD by threefold (n ϭ 3, **p Ͻ 0.01; Fig. 1G ,H ), to a similar level to the binding of 2-AP2 to ␤3 deletion 6 (␤3 ⌬395-414 ). However, the mutation of the dileucine motif to alanines had no significant effect on the binding of 2-AP2 to the ␤3 ICD, and mutation of both motifs (␤3 7AϩILL/AAA ) had a similar effect to the 7A mutant alone, suggesting that the dileucine motif does not significantly contribute to the interaction with 2-AP2. These experiments also corroborate the results from Figure 1 B-E, which show no decrease in binding to AP2 with deletion 3, which contains the putative dileucine motif. Similar results were obtained from pulldown experiments with rat brain homogenate with binding of 2-AP2 to the ␤3 ICD mutants mirroring the in vitro pull-down assays (n ϭ 6, *p Ͻ 0.05; Fig. 1 I, J ) . These results support a key role for a 7 aa motif ( 400 KKTHLRRR 407 ) within the GABA A R ␤3-subunit ICD in mediating the interaction with AP2.
Molecular determinants of the ␤3-subunit/AP2 interaction
To further identify the key residues within the 400 KKTHLRRR 407 motif that mediate AP2 binding, we sequentially mutated the seven basic amino acids (shown in Fig. 2 A) within GST-␤3 ICD to alanine, generating GST-␤3 KK/AA , GST-␤3 TH/AA , and GST-␤3 RRR/AAA mutants, which were then used in pull-down experiments with rat brain homogenate (Fig. 2 B) . Quantification of AP2 binding by densitometry showed a large decrease in the binding of AP2 to the GST-␤3 RRR/AAA mutant compared with the binding to the GST-␤3
WT , GST-␤3 KK/AA , and GST-␤3 TH/AA fusion proteins (n ϭ 3, *p Ͻ 0.05; Fig. 2C ), suggesting that these three arginine residues are essential for the binding of the ␤3 ICD to AP2. AP2 comprises a heteromer of ␣, ␤2, 2, and 2 adaptin subunits (Collins et al., 2002) . We further confirmed that the RRR motif mediates interaction with heteromeric AP2 endogenous complexes as revealed by WB with a ␤2 adaptin antibody B, In vitro translated 35 S-labeled 2 was subjected to pull-down experiments with deletion ␤3 ICD GST fusion proteins. IN, Input. C, Quantification of 2 binding shows a significant decrease in binding to deletion 6 (⌬395-414) (n ϭ 5, *p Ͻ 0.05). D, Pull-down experiments with rat brain lysate with the deletion ␤3 ICD GST fusion proteins. Protein complexes were analyzed by SDS-PAGE and Western blotting with an antibody to AP2. E, Densitometric quantification of endogenous AP2 binding to deletion ␤3 ICDs reveals a significant decrease in binding of AP2 to deletion 6 (⌬395-414) (n ϭ 4, *p Ͻ 0.05). F, Amino acid sequence of the GABA A R ␤3-subunit ICD. Deletion 6 (⌬395-414) is shown by the black line. Basic residues that may be a putative AP2 binding site are highlighted in dark gray and are mutated to alanine in the ␤3 7A mutant construct. A putative dileucine motif is highlighted in light gray. G, In vitro translated 35 S-labeled 2 was subjected to pull-down experiments with ␤3-subunit mutant GST fusion proteins. H, Quantification of 2 binding showing that the mutation of seven basic residues (␤3 7A ) within the region 395-414 significantly reduces binding of 2tothe␤3 ICD (n ϭ 3, **p Ͻ 0.01). I, Pull-down experiments in rat brain lysate with the deletion ␤3-subunit mutant GST fusion proteins. Protein complexes were analyzed by SDS-PAGE and Western blotting with an antibody to AP2. J, Quantification of endogenous AP2 binding to ␤3-subunit mutant ICDs showing the mutation of seven basic residues significantly reduces the binding of endogenous AP2 to the ␤3 ICD (n ϭ 6, *p Ͻ 0.05), but the mutation of the dileucine motif has no significant effect on AP2 binding. (Fig. 2 B) . Direct binding of 2-AP2 to the RRR motif was further confirmed by in vitro pull-down assays using GST-␤3
WT and GST-␤3 RRR/AAA with bacterially expressed His-2 (Fig. 2 D) , which also showed a large decrease in the direct binding of His-2-AP2 to GST-␤3 RRR/AAA compared with GST-␤3 WT .
The amino acid residues within the 2 subunit of AP2 responsible for the interaction with the ␤3 ICD are not known. Atypical basic-patch motif containing membrane cargo (such as Syt-1) are known to interact with subdomain B of 2-AP2 (residues 283-394). In the case of Syt-1, key residues within this region of 2- and their sequential mutation to alanine residues (blue). B-D, The arginine residues in the ␤3 subunit mediate its interaction with AP2. B, Pull-down experiments in rat brain lysate with WT, KK, TH, and RRR ␤3 ICD mutant GST fusion proteins. Protein complexes were analyzed by SDS-PAGE and Western blotting with antibodies to the ␤2 and 2 subunits of the AP2 complex. C, Quantification of AP2 binding by densitometry showed a large 3.6-fold decrease in binding to GST-␤3 RRR/AAA (n ϭ 3, *p Ͻ 0.05), whereas there was no significant decrease in binding to the KK or TH mutants. D, In vitro pull-down experiments with the ␤3-subunit mutant GST fusion proteins with and without His-2. Protein complexes were analyzed by SDS-PAGE and stained with Coomassie blue. E, In vitro pull-down experiments with the ␤3-subunit GST fusion protein and WT His-2 and lysine mutants of His-2. Protein complexes were analyzed by SDS-PAGE and stained with Coomassie blue. F, G, The ␤3-subunit ICD and EGFR bind distinct regions of 2-AP2. F, In vitro pull-down experiments with Syt-1-GST, ␤3-GST, EGFR-GST, and GST as a control, and WT His-2, K354E-His-2, and Syt-1mut-His-2 (which is incapable of binding to Syt-1). Protein complexes were analyzed by SDS-PAGE and stained with Coomassie blue. G, SPR sensograms showing binding of WT and mutant His-2 to ␤3-basic patch and FYRALM peptides, demonstrating that the K354E mutation in 2 reduces its affinity for the ␤3 peptide but not for the EGFR peptide. K D values are given in the figure. N/D, No interaction was detectable. RU, Response units.
AP2 are important for the binding of Syt-1 (Haucke et al., 2000) . We therefore tested the binding of His-2, containing a series of lysine (K) residue mutations, to the GST-␤3 fusion protein by performing pull-down assays with variants of 2 containing key K residues in subdomain B mutated (Fig. 2 E) . These experiments revealed that mutation of K354 to glutamate (E) within His-2 is sufficient to abolish its binding to the ␤3 ICD (Fig. 2 E) , suggesting that this residue is critical for ␤3-subunit-AP2 complex formation. To support this finding, additional pull-down experiments were performed with wild-type His-2, mutant K354E-His-2 (its binding to ␤3 abolished), and, as an additional control, His-2-Syt-1mut (with key additional subdomain B residues mutated preventing its binding to Syt-1: K343A, Y344A, K345E, E348A, K354E, and K356E) and GST-␤3 (Fig. 2 F) . This revealed that the K354E-His-2 and His-2-Syt-1mut mutants exhibited significantly reduced binding to GST-␤3 (and with GST-Syt-1, as a control) but could still interact with GST fusion protein of the C-terminal tail of the EGF receptor (EGFR) (residues 995-1045), which associates with a different region of 2-AP2 via tyrosine-based endocytic motifs (Owen and Evans, 1998) (Fig. 2 F) . The key role of His-2 for ␤3 binding was further supported by SPR experiments that compared the binding affinities of His-2 and His-2-K354E to a 401 KTHLRRRSS 409 peptide (the ␤3 ICD basic patch motif) or FYRALM peptide (an EGFR-derived tyrosine-based endocytic motif). Both endocytic sorting motif peptides bind to wild-type His-2 with a similar K D value of ϳ1 M. In agreement with the GST pull-downs (Fig. 2 F) , the SPR experiments showed that the 2 K354E mutation selectively prevents binding to the basic atypical motif within the ␤3 ICD but not to the tyrosine motif within the EGFR peptide (Fig.  2G ). These observations lead to the conclusion that the GABA A R ␤3-subunit binds 2-AP2 via a minimal 405 RRR 407 motif, to a domain within 2-AP2, which is distinct from the C-terminal pocket region of 2-AP2 that binds tyrosine-based motifs such as those within EGFR.
AP2-␤3-subunit interactions stabilize GABA A Rs at EZs but not synapses
Having identified a key AP2-binding site in GABA A R ␤3 subunits, we proceeded to investigate the role of ␤3-subunit-mediated AP2 binding for regulating the dynamics of GABA A Rs at EZs in hippocampal neuronal dendrites. As a prelude to investigating the role of AP2 adaptor interactions in stabilizing GABA A Rs to EZs, we initially characterized the membrane dynamics of ␤3-subunitcontaining receptors in dendrites with respect to EZs. To test this, we visualized single GABA A R-containing myc-epitope-tagged wildtype GABA A R ( myc ␤3 WT ) subunits, using QD tracking (Muir et al., 2010) , a well-established method for following the behavior of single receptors in the surface membrane (Triller and Choquet, 2008) . To examine GABA A R mobility using this method in relation to regions of endocytosis in the neuronal plasma membrane, we simultaneously labeled EZs by cotransfecting neurons with YFP-tagged clathrin light chain, which has been used previously to label these subdomains in dendrites (Blanpied et al., 2002; Petrini et al., 2009) . Single myc-tagged GABA A Rs were labeled using a low concentration of rabbit anti-myc antibody in conjunction with an anti-rabbit secondary coupled to 605 nm QDs. Single QD-labeled myc ␤3 WT -containing GABA A Rs could be observed to rapidly diffuse into and out of EZs (Fig. 3A,B) , Kolmogorov-Smirnov (K-S) test (Fig. 3C) (Fig. 3D) ]. In agreement with mutant receptors being less stable at EZs, mutation of the three arginine residues caused a significant decrease in the mean time spent by GABA A Rs at EZs ( , 0.42 Ϯ 0.03 s, n ϭ 11 cells; *p ϭ 0.05), suggesting that mutation of the RRR motif disrupts the interaction required to stabilize GABA A Rs at dendritic EZs before their endocytosis.
We also investigated the mobility and residency time of individual myc
␤3
RRR/AAA -containing GABA A Rs at inhibitory synapses. Inhibitory presynaptic terminals were live labeled using an antibody to the luminal domain of the GABA transporter VGAT, coupled to the fluorophore Oyster-488 (Martens et al., 2008) , which we confirmed were GAD-6 positive (Fig. 3E,F ; ***p ϭ 2 ϫ 10
Ϫ16
, K-S test). This is likely attributable to the fact that EZs (at which mutant receptors are faster than wild-type receptors) are found extrasynaptically. In agreement with the finding that wild-type and mutant receptor mobilities are similar at synapses, we found no difference in the mean time spent by these receptors at synapses ( 
Mutation of three arginine residues within the ␤-subunit ICD impairs GABA A R endocytosis
We predicted that, because myc ␤3 RRR/AAA mutant-containing GABA A Rs are less efficiently recruited to EZs and spend less time at these sites, the endocytosis of these mutant receptors would be disrupted. To test this, we performed antibody feeding experiments with COS-7 cells expressing ␣1 myc
␤3
WT or ␣1 myc ␤3 RRR/AAA GABA A Rs and GFP (Fig. 4A) . Quantification of GABA A R internalization by normalization of the internalized receptor area to the total cell area (as given by GFP fluorescence, arbitrary units) revealed a significant decrease in ␣1 
WT receptors (2.92 Ϯ 0.50, n ϭ 3, *p Ͻ 0.05). Similar antibody feeding assays were performed on COS-7 cells cotransfected with other ␤3-subunit mutants analyzed for AP2 binding in Figure 1 In similar experiments with COS-7 cells cotransfected with RFP-rab5, an early endosomal marker (Fig. 4C) , quantification of the colocalization of internalized receptors with rab5-labeled compartments revealed that RRR mutant GABA A Rs displayed significantly decreased colocalization with rab5 compared with WT receptors ( myc ␤3 WT , 24.0 Ϯ 0.4%; myc ␤3 RRR/AAA , 12.5 Ϯ 1.4%; n ϭ 4, **p Ͻ 0.01; Fig. 4C ). This was also the case with the other mutant receptors, revealing decreased colocalization with rab5-labeled compartments for the ␣1 Fig. 4 D) . However, ␣1 myc ␤3 ILL/AAA mutant receptors displayed almost identical levels of colocalization with rab5 as wild-type receptors (30.68 Ϯ 2.98%, p ϭ 0.7), suggesting that the dileucine motif does not play a significant role in the endocytosis of ␣1␤3-containing receptors to the early endosome compartment in COS-7 cells.
To also test whether a similar mechanism of GABA A R endocytosis occurs in neurons, we transfected neurons with myc ␤3
WT or myc ␤3 RRR/AAA constructs, which assemble with endogenous subunits in neurons (data not shown), and performed a similar RRR/AAA ) and GFP were live labeled with anti-myc antibody and placed at 37°C for 30 min to allow internalization of receptors. Remaining surface antibody was stripped away and cells were fixed, (Figure legend continues.) antibody feeding protocol. Surface receptors were labeled with myc antibody, left to internalize at 37°C for 30 min, and then fixed and blocked under nonpermeabilizing conditions. Surface receptors were labeled with Alexa Fluor 488-conjugated secondary antibody (green; surface), and, after permeabilization, all myc-tagged receptors were labeled with Alexa Fluor-594-conjugated secondary antibody (red; total), enabling the internalized receptors to be quantified (Fig. 4 E) . Quantification of the internalized pool of receptors (red fluorescence) showed a 72.0 Ϯ 5.0% decrease in the endocytosis of the mutant myc ␤3 RRR/AAAcontaining GABA A Rs compared with wild-type receptors (n ϭ 3, **p Ͻ 0.01; Fig. 4 E) WT control levels; n ϭ 3, **p Ͻ 0.01; Fig.  4 F, images not shown). In contrast, the myc ␤3 ILL/AAA mutant subunits were not significantly altered in their endocytosis compared with myc ␤3 WT -subunit-containing receptors (32.03 Ϯ 26.23% decrease, p ϭ 0.3). Therefore, in both COS-7 cells and neurons, the mutation of the RRR motif within the ␤3 subunit to alanine residues disrupts the endocytosis of GABA A Rs.
In agreement with these findings, whole-cell ELISAs (Bedford et al., 2001; Mielke and Wang, 2005) WT receptors (n ϭ 3, **p Ͻ 0.01). To support these data, we then used confocal microscopy to quantify the total area of GABA A R clusters in neurons expressing either the myc ␤3 WT or myc ␤3 RRR/AAA constructs. Similarly, the total area of GABA A R clusters in neurons expressing the myc ␤3 RRR/AAA mutant was 68.0 Ϯ 28.2% greater than that of neurons expressing the myc ␤3 WT construct (n ϭ 3, **p Ͻ 0.01; Fig.  4G ). Therefore, mutation of residues ( 405 RRR 407 ) within the ␤3 subunit leads to steady-state accumulation of GABA A Rs at the cell surface and at synapses as a result of a decrease in clathrindependent endocytosis.
The observed alterations in surface levels and lateral mobility of myc ␤3 RRR/AAA mutant GABA A Rs could also possibly be attributable to the effects of NSF, an ATPase that binds to a potentially overlapping region of the ␤3 ICD as AP2 (Goto et al., 2005) and is implicated in GABA A R trafficking (Chou et al., 2010) . To confirm that NSF function was not involved in the observed increased surface expression of myc
RRR/AAA mutant GABA A Rs, we treated COS-7 cells expressing ␣1 myc
WT or ␣1 myc ␤3 RRR/AAA GABA A Rs with an NSF inhibitory peptide (NSFi; fused to the TAT sequence), shown previously to increase GABA A R surface expression, or a scrambled control peptide (Morrell et al., 2005; Chou et al., 2010) . ELISA experiments were then used to verify surface GABA A R levels. The NSFi peptide treatment caused a 35.3 Ϯ 7.2% increase in surface ␣1 myc ␤3 WT GABA A Rs compared with scrambled peptide treatment (Fig. 4 H) . A similar effect on NSF inhibition was also observed for surface ␣1 myc ␤3
RRR/AAA GABA A Rs [47.7 Ϯ 14.08% increase in surface ␣1 myc ␤3
RRR/AAA GABA A Rs on NSFi treatment compared with scrambled peptide treatment (n ϭ 4, *p Ͻ 0.05)]. These results confirm that the myc ␤3 RRR/AAA mutant still undergoes regulatory control by NSFdependent trafficking mechanisms and that the observed increase in surface myc ␤3 RRR/AAA mutant expression is not attributable to altered regulation by NSF via this motif. NSFdependent interactions were also unlikely to play a role in the observed alterations in surface GABA A R lateral mobility of mutant ␤3 RRR/AAA receptors, because QD-imaging experiments revealed that blocking NSF activity had very little effect on the lateral mobility of GABA A Rs at the plasma membrane (data not shown). We therefore conclude that the effects of the RRR/AAA mutation on GABA A Rs at the neuronal cell surface are attributable to the specific disruption of the ␤3/AP2 binding site.
␤3-subunit AP2 interactions are critical for GABA A R depletion from synapses during ischemic insult
An imbalance between excitatory and inhibitory synaptic transmission is thought to contribute to excitotoxicity and neuronal cell death during ischemic insult. Several studies have reported a decrease in surface and synaptic GABA A R expression during ischemia, suggesting an increase in receptor endocytosis (Schwartz-Bloom and Sah, 2001; Mielke and Wang, 2005; Zhan et al., 2006; Kelley et al., 2008; Liu et al., 2010) , but whether this is via an AP2-dependent pathway remains unclear.
To monitor the role of AP2 interactions in GABA A R trafficking, we used a super-ecliptic pHluorin (pH-sensitive GFP) N-terminally tagged ␥2-subunit construct ( SEP ␥2), cotransfected with ␤3 subunits to visualize surface and synaptic GABA A R clusters under normal and ischemic conditions using live-cell imaging techniques. This cotransfection also enabled us to study effects of mutations within both ␥2 and ␤3 subunits. , respectively, indicating a high and similar level of cotransfection for these experiments (data not shown). Similar transfection effi- (Kelley et al., 2008; WT showed that the SEP ␥2 cluster fluorescence remained stable under control conditions (Fig. 5 A, B) . However, during the OGD treatment, there was a significant 21.3 Ϯ 4.0% reduction in surface cluster fluorescence over time compared with the control (n ϭ 12, **p Ͻ 0.01; Fig. 5A,B) . Using this approach, we then investigated whether this downmodulation was dependent on ␤3-subunit/AP2 interactions. In contrast to the A GABA A R AP2-binding domain (YECL) in the ␥2 subunit also exists . In contrast, mutating the YECL AP2-binding domain in the ␥2 subunit (to AECL) led to significant decrease in GABA A R cluster intensity under OGD conditions (*p Ͻ 0.05; Fig. 5G,J ) . However, in neurons cotransfected with myc ␤3 RRR/AAA and SEP ␥2 AECL , GABA A Rs were stable at the cell surface over the OGD time course ( p ϭ 0.77; Fig. 5 H, J ) . Thus, the RRR motif within the ␤3 subunit is more important for control of AP2-mediated GABA A R internalization during OGD insult than the YECL motif on the ␥2 subunit. Therefore, these experiments show that the interaction of the ␤3 subunit with AP2 plays a key role in the loss of synaptic GABA A Rs observed during ischemia. Furthermore, these data reveal that specific targeting of this GABA A R RRR AP2-binding motif could provide resistance for GABA A Rs against their accelerated endocytosis and removal from synaptic sites induced by ischemic insult.
Blockade of the ␤3/AP2 interaction reduces neuronal cell death during ischemic insult
We have revealed that preventing the interaction of GABA A R ␤3 subunit and AP2 can maintain surface GABA A R clusters during OGD. To investigate the functional relevance of this finding, we used a peptide overlapping the AP2 binding region in the ␤3 subunit to compete the ␤3/AP2 interaction in hippocampal neurons (␤3 peptide). The ␤3 peptide and a control peptide (to a region of the ␤3 ICD distinct from the AP2 binding site) were transduced into 12-15 DIV hippocampal neurons for 1 h before OGD insult using a membrane-permeable carrier peptide (Twelvetrees et al., 2010) . Delayed neuronal death was analyzed 24 h later using PI and DAPI staining, and the number of PI-positive nuclei were counted and the cell viability determined (Fig. 6 A, B) . OGD treatment of neurons transduced with the control peptide caused a 30.5 Ϯ 1.6% decrease in cell viability (n ϭ 3, ***p Ͻ 0.001) compared with neurons pretreated with the ␤3 peptide that exhibited an insignificant 6.4 Ϯ 1.4% reduction in cell viability (n ϭ 3, p ϭ 0.09). These data show that specifically blocking the ␤3/AP2 interaction in neurons can prevent OGD-induced delayed cell death, strongly suggesting that GABA A R endocytosis via the RRR motif is important in mediating this process.
Discussion
Regulated trafficking of postsynaptic neurotransmitter receptors is essential for determining the strength of synaptic transmission and for ensuring the correct balance of excitation and inhibition of neuronal circuits (Groc and Choquet, 2006; ). Tightly controlled clathrin-dependent endocytosis of surface GABA A Rs has been specifically shown to control synaptic efficacy in neurons, providing a fast mechanism to modulate synaptic strength and therefore synaptic inhibition (Kittler et al., 2000 . Reduced inhibition attributable to alterations in GABA A R trafficking can also contribute to disrupted information processing and to the detrimental excitotoxicity thought to exacerbate neuronal cell death observed in conditions such as stroke and epilepsy . In this study, we have investigated the internalization mechanisms of ␤3-subunit-containing GABA A Rs under normal and pathological conditions. We have identified a specific RRR motif ( 405 RRR 407 ) within the ␤3-subunit ICD that is essential for the endocytosis of GABA A Rs. We show that these residues mediate the direct interaction with 2-AP2, although K354 within 2-AP2 is also critical for this interaction. Mutation of the ␤3-subunit RRR motif reduces recruitment of GABA A Rs to EZs and impairs their endocytosis, leading to their steady-state accumulation at the neuronal cell surface and at synapses. We also show that downmodulation of GABA A Rs from dendritic clusters during OGD treatment (to simulate ischemia) is dependent on an AP2-dependent pathway for cell-surface removal of receptors. Moreover, blockade of this pathway can reduce the delayed neuronal death observed during ischemic insult.
We focused our study on the internalization of GABA A Rs containing the ␤3 subunit because of its high expression in the hippocampus and cortex and its presence in a large proportion of GABA A R subtypes found in these regions Wisden et al., 1992) . To identify the molecular determinants of GABA A R internalization, we first identified the region of the ␤3-subunit ICD that mediated the interaction with the clathrinadaptor protein AP2. This revealed a 20 aa stretch that harbored a seven residue atypical basic patch motif that, when mutated to alanine, prevented the binding of AP2 to the GABA A R ␤3-subunit ICD. Within this binding motif, additional mapping identified three arginine residues ( 405 RRR 407 ) that are essential for the interaction with 2-AP2 and receptor internalization via an AP2-and clathrin-dependent mechanism. Because 2-AP2 binds to GABA A R subunits ␤1-␤3 and the RRR motif is conserved across all three ␤ subunits, it suggests that these residues might be an internalization signal for all ␤-subunit-containing GABA A Rs. An arginine residue (R845) was also shown to be critical for AMPA receptor GluR2 subunit binding to AP2 (Lee et al., 2002; Kastning et al., 2007) . Atypical basic patch motifs of both AMPA and GABA A Rs bind to the same region of 2-AP2, subdomain B (Kastning et al., 2007 ; and this study), pointing to a similar clathrin-mediated internalization mechanism for both types of postsynaptic neurotransmitter receptors. In contrast, we did not find that a putative dileucine motif within the ␤3 subunit [as suggested for the ␤2 subunit (Herring et al., 2003) ] was required for endocytosis or AP2 binding, suggesting that this motif is not a primary determinant of ␤3-subunit-mediated GABA A R internalization. Interestingly, the ␤3-subunit RRR motif is located adjacent to a phosphorylation site, Ser 408 /Ser 409 , which acts as a key site for GABA A R phosphomodulation by kinases (Brandon et al., 2002) and phosphatases (Jovanovic et al., 2004; Terunuma et al., 2008) . Phosphorylation at this site has been shown to impair GABA A R endocytosis by preventing the interaction of the ␤3-subunit with AP2 (Kittler et tions provided by the arginine residue cluster, thereby disrupting the AP2 binding site.
We have used QD tracking to measure the lateral mobility of GABA A Rs within EZs, specialized clathrin-rich regions along the dendritic plasma membrane, which mediate clathrin-dependent endocytosis (Blanpied et al., 2002) . We found that QD-labeled GABA A Rs could be reversibly recruited to these clathrin-rich structures in which they displayed a reduced lateral mobility compared with receptors outside the EZ, suggesting that the receptors are being confined to these subdomains, before their endocytosis. This is similar to the confined behavior of GABA A Rs observed at the inhibitory postsynaptic site, with similar diffusion coefficient values for the mobility of the receptors previously recorded at the synapse to those observed at EZs (Bannai et al., 2009; Muir et al., 2010) . This suggests that both inhibitory postsynaptic sites and EZs are specialized dendritic subdomains that share similar GABA A R confinement mechanisms via reversible interactions with submembranous synaptic or EZ proteins, such as gephyrin and AP2, respectively. In agreement with this, mutation of the RRR motif to alanine impaired the recruitment of GABA A Rs to EZs, as shown by the 3.3-fold increase in lateral mobility of non-AP2-binding mutant GABA A Rs at clathrin-coated pits compared with their wild-type counterparts. This increase in lateral mobility was accompanied by a significantly decreased residency time for the mutant receptors at EZs and a reduced likelihood of mutant receptors being endocytosed. Mutation of the ␤3-subunit AP2-binding motif did not alter the mobility or residency time of individual GABA A Rs at synaptic sites but did increase the steady-state levels of surface and synaptic receptors as a result of diminished receptor endocytosis. These results clearly demonstrate the key role of direct interactions of GABA A R ICDs with AP2 for recruiting and confining GABA A Rs at endocytic sites. This allows the trapping of mobile receptor populations at these membrane compartments within the plasma membrane to enable GABA A Rs to either mediate phasic inhibition at the synapse or undergo receptor endocytosis at the EZ.
During cerebral ischemia, overexcitation as a result of excessive glutamate release contributes to excitotoxicity and cell death in susceptible neuronal populations (Lipton, 1999; Lo et al., 2003) . Research into therapeutics to treat ischemia has focused primarily on the glutamatergic system and the reduction of excess glutamatergic signaling during ischemic insult, but these have not proven to be clinically effective (Schwartz-Bloom and Sah, 2001). GABAergic transmission and GABA A R endocytosis are also significantly altered in ischemia, which may contribute to disinhibition and pathological excitability states. Because glutamatergic neurotransmission is counterbalanced by the GABAergic system, modulation of GABA metabolism and GABA A R function may be alternative targets of therapeutic intervention for ischemia. An in vitro model of cerebral ischemia, OGD, has been shown to modulate GABA A R trafficking, reducing surface expression of receptors (Mielke and Wang, 2005 ; Liu et al., 2010) Figure 6 . Blockade of GABA A R endocytosis reduces OGD-induced delayed cell death. Twelve to 15 DIV hippocampal neurons were transduced with control or ␤3 peptides for 1 h before a 40 min OGD treatment. Twenty-four hours later, neurons were stained with PI and DAPI, and the PI-positive nuclei were counted. A, Representative confocal images of control and ␤3 peptide transduced neurons under control and OGD conditions. Scale bar, 40 m. B, Bar graph summarizing the pooled data (n ϭ 3, ***p Ͻ 0.001).
and increasing ubiquitin-dependent lysosomal receptor degradation . Previous studies using hypertonic sucrose treatment or dynamin inhibitors have suggested that pathological GABA A R endocytosis in OGD or status epilepticus is attributable to clathrindependent endocytosis (Goodkin et al., 2005; Mielke and Wang, 2005) . However, hypertonicity has multiple cellular effects (Rosenmund and Stevens, 1996; Carroll et al., 1999) , and dynamin inhibitors may block other (e.g., caveolar) endocytosis pathways (Nabi and Le, 2003; Doherty and McMahon, 2009 ). By imaging super-ecliptic pHluorin-tagged GABA A Rs, we show a decrease in synaptic GABA A R clusters during OGD treatment of hippocampal neurons for 30 min, which is consistent with other studies (Mielke and Wang, 2005; Liu et al., 2010) . Using the ␤3-subunit RRR motif mutant, we then directly tested the pathway of pathological GABA A R endocytosis during OGD and showed that acute loss of synaptic GABA A Rs during OGD is mediated by an AP2 and clathrin-dependent internalization pathway. Furthermore, blocking this internalization pathway with a competing ␤3 peptide can reduce delayed cell death after OGD insult, demonstrating the physiological relevance of this mechanism in neuronal function.
We also find that the tyrosine motif within the ␥2 subunit has little effect on endocytosis of GABA A Rs during OGD, suggesting that the ␤3-subunit RRR motif is the primary determinant of internalization during simulated ischemic insult. This is probably attributable to the different binding affinities of the subunits for AP2 and their regulation by different kinase families (Kittler et al., 2005 , allowing multiple signaling pathways to converge at these receptor ICDs, to enable the fine-tuning of endocytosis modulation in response to a variety of extracellular signals.
In summary, we have identified a triple arginine motif that mediates direct binding of the GABA A R ␤3 subunit to the clathrin adaptor protein AP2. Mutation of this motif impaired receptor recruitment to clathrin-coated pits, significantly reduced receptor endocytosis, and caused an accumulation of surface GABA A Rs in neurons. This AP2 pathway is likely to play a key role in regulating synaptic receptor number during inhibitory synaptic plasticity. In ischemia, synaptic GABA A Rs are also depleted by this AP2/clathrin-dependent pathway. This internalization pathway might therefore also be targeted therapeutically to maintain surface GABA A R populations and synaptic inhibition during pathological insults such as epilepsy and ischemic neuronal death.
